Pediatric Hematology and Oncology

Papers
(The TQCC of Pediatric Hematology and Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Environmental health disparities in pediatric cancer: a report from the Fourth Symposium on Childhood Cancer Health Disparities12
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients11
The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM)11
Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant10
The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma9
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers9
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting9
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis8
Myelofibrosis associated with immune cytopenia in an infant: a diagnostic and therapeutic challenge8
Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature8
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii8
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis8
GATA2-related myeloid neoplasms in pediatrics: where do we stand?8
Factors Related to the Quality of Life in Children with Transfusion-Dependent Thalassemia7
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument7
Response to neoadjuvant selpercatinib in a pediatric patient with advanced papillary thyroid carcinoma: a case report7
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report7
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature7
Effect of platelet count and platelet transfusion on fever duration in patients with febrile neutropenia6
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India6
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study5
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting5
Temporal trends and unbalanced distribution, in pediatric cutaneous melanoma in 204 countries and territories, 1990-20195
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist5
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review5
Comparative analysis of a novel next-generation sequencing-based IGH clonality assay for measurable residual disease detection in pediatric B-cell acute lymphoblastic leukemia patients5
MiR-143-3p Inhibits Cell Proliferation in Pedatric Acute Myeloid Leukemia via Inhibition of KAT6A5
Infectious Complications During Reinduction in Children with Relapsed Acute Lymphoblastic Leukemia: A Descriptive Analysis5
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma4
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study4
Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A4
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy4
Haploidentical hematopoietic cell transplant for severe aplastic anemia in children with carbapenem-resistant enterocolitis4
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion4
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India4
Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board4
The Onset of Puberty Presents Unique Management Issues in Penile Chronic Graft-versus-Host Disease Requiring Circumcision in Male Pediatric Patients4
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative4
The relationship between circulating tumor cells in peripheral blood and clinical characteristics of pediatric neuroblastoma and prognostic evaluation4
Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia4
Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC4
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience4
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study4
The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial3
Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience3
Letter to editor regarding “Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument”3
Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review3
Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia3
Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results of an Open-Label, Single-Arm Phase 4 Trial3
Substrate oxidation during exercise in childhood acute lymphoblastic leukemia survivors3
Diverse outcomes in extra-cranial rhabdoid tumors: A single institute experience3
The efficacy of oral L-arginine therapy for the treatment of vaso-occlusive pain episodes in children with sickle cell disease3
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome3
Pediatric AML: state of the Art and Future Directions3
Psychosocial and mental profile of children with sickle cell disease and their caregivers3
Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of LEF13
German physicians’ perceptions and views on complementary medicine in pediatric oncology: a qualitative study3
0.07007908821106